Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An evaluation of nivolumab and ipilimumab for the treatment of resectable stage III melanoma.

Expert review of anticancer therapy·2025
Same author

Pre-referral ultrasound for cryptorchidism: Still common, still not necessary.

Journal of paediatrics and child health·2024
Same author

Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients.

Molecular cancer research : MCR·2021
Same author

Detection rates of missing microsurgical needles using intra-operative imaging.

ANZ journal of surgery·2020
Same author

Caesarean section improves neonatal outcomes only from 24 + 0 weeks for periviable breech but not for cephalic infants.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2019
Same author

Delayed presentation of large intra-abdominal wooden splinter after blunt trauma: a case report.

ANZ journal of surgery·2018

Related Experiment Video

Updated: Jan 13, 2026

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.4K

Interdigitating Dendritic Cell Sarcoma: A Rare Diagnostic Challenge.

Grace Elizabeth Boyd1, Alistair McCombe, Gerard Bayley

  • 1From the Princess Alexandra Hospital, Brisbane, Australia.

Annals of Plastic Surgery
|January 12, 2026
PubMed
Summary

Interdigitating dendritic cell sarcoma (IDCS) is a rare cancer with no standard treatment. This case highlights diagnostic challenges, particularly its similarity to melanoma, emphasizing the need for more research.

Keywords:
diagnosishead and neck cancerinterdigitating dendritic cell sarcoma

More Related Videos

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.5K
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.2K

Related Experiment Videos

Last Updated: Jan 13, 2026

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.4K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.5K
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.2K

Area of Science:

  • Oncology
  • Pathology
  • Surgical Oncology

Background:

  • Interdigitating dendritic cell sarcoma (IDCS) is a rare malignancy with a poor prognosis.
  • A standardized treatment protocol for IDCS is currently lacking.
  • IDCS poses diagnostic challenges due to immunophenotypic overlap with other malignancies, including melanoma.

Purpose of the Study:

  • To describe a case of IDCS in the head and neck.
  • To highlight diagnostic findings and the overlap with melanoma.
  • To contribute to the limited literature on IDCS, particularly in the head and neck region.

Main Methods:

  • Case presentation of a 52-year-old woman with a left cervical mass.
  • Diagnostic workup including histopathological examination and immunohistochemistry.
  • Surgical intervention involving unilateral modified radical neck dissection and superficial parotidectomy.

Main Results:

  • IDCS was confidently diagnosed despite morphological and immunohistochemical overlap with melanoma.
  • The case adds to the limited published data on head and neck IDCS since the last pooled analysis.
  • Unique diagnostic findings were identified and explored in relation to melanoma.

Conclusions:

  • Further data on treatment outcomes and follow-up for IDCS are necessary.
  • Increased case reporting is crucial for future analyses to guide the management of this rare malignancy.
  • This case underscores the diagnostic complexities of IDCS, especially its differentiation from melanoma.